A new market-oriented approach to product development, more
favourable licensing arrangements, strategic acquisitions and a
fresh crop of proprietary drug-delivery technologies helped UK
company BioProgress to deliver an adjusted...
British company Q Chip has upped the stakes in the drug delivery
market with its new tailor-made bioencapsulation technology,
claiming to improve drug effectiveness, reduce side effects and
increase patient acceptance.
Japanese packaging machinery firm Shibuya Kogyo is close to
finalising its acquisition of Hoppmann, a move that will expand the
firm's presence within the lucrative US market.
Microfluidics has launched the first research-scale versions of its
patented High-Pressure Multiple Stream Mixer Reactor (MMR), claimed
to create uniform particles smaller than anything achieved using
current technologies.